TARIS™ Platform

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf platform
gptkbp:aimsTo patient outcomes
time to market for drugs
gptkbp:collaboratesWith academic institutions
gptkbp:developedBy gptkb:TARIS_Biomedical
gptkbp:enables personalized treatment plans
gptkbp:enhances therapeutic development
gptkbp:facilitates regulatory submissions
gptkbp:focusesOn precision medicine
gptkbp:hasRelatedPatent clinical trials
https://www.w3.org/2000/01/rdf-schema#label TARIS™ Platform
gptkbp:integratesWith clinical workflows
gptkbp:isAttendedBy healthcare_providers
gptkbp:isBasedOn advanced analytics
gptkbp:isCompatibleWith various sample types
gptkbp:isDesignedFor improve diagnostic accuracy
oncology applications
gptkbp:isEnhancedBy machine learning
gptkbp:isEvaluatedBy clinical trials
clinical studies
gptkbp:isFocusedOn early detection of diseases
improving patient care
gptkbp:isIntegratedWith laboratory information systems
healthcare_systems
gptkbp:isLinkedTo patient stratification
gptkbp:isPartOf biomedical research
biotechnology industry
precision medicine initiatives
the future of medicine
gptkbp:isPromotedBy scientific publications
gptkbp:isPromotedThrough partnerships
gptkbp:isRecognizedBy gptkb:FDA
gptkbp:isRecognizedFor innovation in diagnostics
a leading platform in oncology
gptkbp:isSupportedBy venture capital
scientific research
clinical evidence
gptkbp:isTargetedAt healthcare_professionals
gptkbp:isUsedIn diagnostic testing
gptkbp:isUtilizedFor pharmaceutical companies
treatment monitoring
biomarker validation
gptkbp:isUtilizedIn research collaborations
gptkbp:isVisitedBy cancer research
collaborative research efforts
gptkbp:offers real-time data analysis
gptkbp:provides comprehensive reporting
analytical services
gptkbp:providesAccessTo genomic data
gptkbp:supports biomarker_discovery
gptkbp:usedFor drug development
gptkbp:utilizes liquid biopsy technology